ClinicalTrials.govpublic full text
Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers
pancreatic cancer, colorectal cancer, non-small cell lung cancer, kras mutation-related tumors, shp2, erk, combination therapy, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 842057
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.